| Class 2 Device Recall 300 microliter CORE tips | |
Date Initiated by Firm | December 01, 2008 |
Date Posted | April 17, 2009 |
Recall Status1 |
Terminated 3 on July 21, 2009 |
Recall Number | Z-1203-2009 |
Recall Event ID |
50529 |
Product Classification |
Device, microtiter diluting/dispensing - Product Code JTC
|
Product | 300 microliter CO-RE tips for use with Microlab STAR series instruments, Part Number 235902, 5,760 tips per case, manufactured by Hamilton Company, Reno, NV.
The products are a disposable product that are used with the Microlab STAR series instruments, which are microtiter diluting and dispensing devices. |
Code Information |
Lot Number: 2873900. |
Recalling Firm/ Manufacturer |
Hamilton Co 4970 Energy Way Reno NV 89502-4123
|
For Additional Information Contact | 775-858-3000 Ext. 236 |
Manufacturer Reason for Recall | Some tips may be occluded and are unable to aspirate or dispense liquid. |
FDA Determined Cause 2 | Process control |
Action | An "Urgent: Product Recall Letter" dated December 1, 2008 was issued to consignees via certified mail and e-mail. The letter described the problem and potential effects of use. Consignees were instructed to complete the enclosed "Hamilton Company Product Recall Questionnaire" and return it via e-mail or fax (775-856-7259) to the Hamilton Company. After receipt of the completed questionnaire, the firm's Customer Service Department will contact consignees to provide Returned Material Authorization information for returning affected product. Direct questions to the Hamilton Company at 775-858-3000, ext. 236. |
Quantity in Commerce | 28 cases |
Distribution | Nationwide Distribution -- MA, CA, MN, CT, and NC. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|